Topics

Glioblastoma | Diagnosis | PET/MRI

Home > Publications > Topics > Glioblastoma > Diagnosis > PET/MRI

Ivanidze J, Vu KV, Fu R, Brandmaier A, Szidonya L, Choudhary G, Starkey J, Wang TJ, Sisti M, McKhann LG, Puri S, Konner M, Roytman M, Lin E, Kuhn A, Osborne JR, Stieg PE, Beal K, Ramakrishna RR, Singh G, Lignelli-Dipple A, Doubrovin M, Vo AH, Welch M, Iwamoto F, Haggiagi A, Donovan L, Diaz M, Gill B, Liechty B, Pisapia DJ, Walker J, Magge RS, Wood M, Corzo VM, Sanusi OR, Raslan A, Dogan A, Bowden S, Nehmeh SA, Nickerson J, Mallak N, Ruiz A, Ambady P, Nabavizadeh A, Barajas RF Jr.
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma.
AJNR Am J Neuroradiol. 2025 Dec 1:ajnr.A9120. doi: 10.3174/ajnr.A9120. PMID: 41326230. Observational study. ˍ